Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karim Dorgham

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Viruses|October 14, 2011
CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosisMichèle Février, Karim Dorgham, Angelita Rebollo
Arthritis & Rheumatology (Hoboken, N.J.)|August 31, 2019
ReplyAlexis Mathian, Suzanne Mouries-Martin, Karim Dorgham, et al.
Human Gene Therapy Methods|July 22, 2014
Targeting both viral and host determinants of human immunodeficiency virus entry, using a new lentiviral vector coexpressing the T20 fusion inhibitor and a selective CCL5 intrakineNicolas Petit, Karim Dorgham, Béatrice Levacher, et al.
Plos One|June 24, 2016
Identification of the Single Immunodominant Region of the Native Human CC Chemokine Receptor 6 Recognized by Mouse Monoclonal AntibodiesKarim Dorgham, Cécile Dejou, Christophe Piesse, et al.
Blood|August 21, 2013
Identification of a cellular ligand for the natural cytotoxicity receptor NKp44Florence Baychelier, Alexis Sennepin, Myriam Ermonval, et al.
Lancet (London, England)|July 25, 2021
Tocilizumab in COVID-19 therapy: who benefits, and how?Avidan U Neumann, Mehmet Goekkaya, Karim Dorgham, et al.
American Journal of Respiratory and Critical Care Medicine|March 16, 2021
Longitudinal Cytokine Profiling in Patients with Severe COVID-19 on Extracorporeal Membrane Oxygenation and HemoadsorptionGuillaume Lebreton, Karim Dorgham, Paul Quentric, et al.
Vaccine|May 16, 2008
Engineered CCR5 superagonist chemokine as adjuvant in anti-tumor DNA vaccinationKarim Dorgham, Valérie Abadie, Mutsunori Iga, et al.
Pharmaceutics|October 27, 2022
Binding and Kinetic Analysis of Human Protein Phosphatase PP2A Interactions with Caspase 9 Protein and the Interfering Peptide C9hKarim Dorgham, Samuel Murail, Pierre Tuffery, et al.
Rheumatology (Oxford, England)|February 13, 2025
Comment On: Association of serum interferon alpha-2a levels with disease severity and prognosis in systemic sclerosisKarim Dorgham, Maude Calixte, Omaira Da Mata Jardin, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Viruses|October 14, 2011
CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosisMichèle Février, Karim Dorgham, Angelita Rebollo
Arthritis & Rheumatology (Hoboken, N.J.)|August 31, 2019
ReplyAlexis Mathian, Suzanne Mouries-Martin, Karim Dorgham, et al.
Human Gene Therapy Methods|July 22, 2014
Targeting both viral and host determinants of human immunodeficiency virus entry, using a new lentiviral vector coexpressing the T20 fusion inhibitor and a selective CCL5 intrakineNicolas Petit, Karim Dorgham, Béatrice Levacher, et al.
Plos One|June 24, 2016
Identification of the Single Immunodominant Region of the Native Human CC Chemokine Receptor 6 Recognized by Mouse Monoclonal AntibodiesKarim Dorgham, Cécile Dejou, Christophe Piesse, et al.
Blood|August 21, 2013
Identification of a cellular ligand for the natural cytotoxicity receptor NKp44Florence Baychelier, Alexis Sennepin, Myriam Ermonval, et al.
Lancet (London, England)|July 25, 2021
Tocilizumab in COVID-19 therapy: who benefits, and how?Avidan U Neumann, Mehmet Goekkaya, Karim Dorgham, et al.
American Journal of Respiratory and Critical Care Medicine|March 16, 2021
Longitudinal Cytokine Profiling in Patients with Severe COVID-19 on Extracorporeal Membrane Oxygenation and HemoadsorptionGuillaume Lebreton, Karim Dorgham, Paul Quentric, et al.
Vaccine|May 16, 2008
Engineered CCR5 superagonist chemokine as adjuvant in anti-tumor DNA vaccinationKarim Dorgham, Valérie Abadie, Mutsunori Iga, et al.
Pharmaceutics|October 27, 2022
Binding and Kinetic Analysis of Human Protein Phosphatase PP2A Interactions with Caspase 9 Protein and the Interfering Peptide C9hKarim Dorgham, Samuel Murail, Pierre Tuffery, et al.
Rheumatology (Oxford, England)|February 13, 2025
Comment On: Association of serum interferon alpha-2a levels with disease severity and prognosis in systemic sclerosisKarim Dorgham, Maude Calixte, Omaira Da Mata Jardin, et al.
Pageof 10